Impaired Cognition Clinical Trial
Official title:
The Impact of Family Financial Support on Cognition
Verified date | October 2017 |
Source | University of California, Los Angeles |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators have partnered with financial coaching organizations to establish what the investigators have termed a "Medical-Financial Partnership (MFP)" that offers financial coaching to improve financial and mental health. The investigators will evaluate the MFP's impact on cognition using the Patient Reported Outcomes Measurement Information System (PROMIS) Cognition Short form 8a.
Status | Completed |
Enrollment | 150 |
Est. completion date | October 2017 |
Est. primary completion date | October 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Participants will be included if they are caregivers/parents of one or more dependents, have some form of income, and have a tax identification number. Exclusion Criteria: - Inability to take part in financial coaching due to disability or primary language other than English or Spanish. |
Country | Name | City | State |
---|---|---|---|
United States | LIFT-LA | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Los Angeles |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cognition | Cognitive abilities will be assessed using the PROMIS Cognitive Abilities Survey short form 8a | Up to one year (if possible) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04006756 -
A Study on Better Cognitive Functioning Through Braintraining on the Internet
|
N/A | |
Active, not recruiting |
NCT02920632 -
Cognitive Training in Parkinson Study
|
N/A | |
Completed |
NCT01714661 -
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
|
Phase 3 | |
Completed |
NCT01716975 -
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
|
Phase 3 | |
Active, not recruiting |
NCT02182817 -
Exposure to General Anaesthesia in Infancy and Neurocognitive Development
|
||
Completed |
NCT01713491 -
Pre-stroke Cognitive Status and Thrombolytic Therapy
|
N/A | |
Recruiting |
NCT01315704 -
Alzheimer's Disease and Related Disorders
|
N/A | |
Completed |
NCT01315717 -
Gait and Alzheimer Interaction Tracking (GAIT) Study
|
N/A | |
Completed |
NCT01006330 -
Dysphagia in Elderly Medical Patients
|
Phase 4 | |
Completed |
NCT01818778 -
The Efficacy of Using Volunteers to Implement a Cognitive Stimulation Program in Two Long-Term Care Homes
|
N/A | |
Recruiting |
NCT01314638 -
Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio)
|
N/A | |
Completed |
NCT01739933 -
The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure
|
Phase 3 | |
Completed |
NCT02936401 -
Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders
|
N/A | |
Terminated |
NCT03095170 -
Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder
|
N/A | |
Terminated |
NCT03504501 -
Synaptic Plasticity and Cognitive Function in RASopathies
|
Phase 2 | |
Recruiting |
NCT02290834 -
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
|
N/A | |
Completed |
NCT03064308 -
The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery
|
N/A | |
Completed |
NCT02265757 -
Behavioral Interventions to Prevent or Delay Dementia
|
N/A | |
Completed |
NCT01714713 -
A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
|
Phase 3 | |
Recruiting |
NCT01490567 -
A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia
|
Phase 4 |